3,5-diiodothyronine has been researched along with Atherosclerosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dörr, M; Heßelbarth, L; Ittermann, T; Köhrle, J; Lehmphul, I; Lorbeer, R; Mensel, B; Quadrat, A; Schneider, T; Völzke, H; Wenzel, M | 1 |
| Cioffi, F; Goglia, F; Lanni, A | 1 |
1 review(s) available for 3,5-diiodothyronine and Atherosclerosis
| Article | Year |
|---|---|
Thyroid hormones, mitochondrial bioenergetics and lipid handling.
Topics: Acetates; Adiposity; Anilides; Animals; Atherosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Diiodothyronines; Dyslipidemias; Energy Metabolism; Fatty Liver; Humans; Lipid Metabolism; Mice; Mitochondria; Obesity; Phenols; Rats; Thyroid Hormones | 2010 |
1 other study(ies) available for 3,5-diiodothyronine and Atherosclerosis
| Article | Year |
|---|---|
High levels of thyroid-stimulating hormone are associated with aortic wall thickness in the general population.
Topics: Adult; Aged; Aged, 80 and over; Aorta; Aortic Diseases; Atherosclerosis; Diiodothyronines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multivariate Analysis; Organ Size; Thyrotropin; Young Adult | 2016 |